BioCentury
ARTICLE | Clinical News

IV finafloxacin: Phase II started

December 17, 2012 8:00 AM UTC

MerLion began a double-blind, double-dummy, European Phase II trial to compare 3.2 mg/mL IV finafloxacin and 200 mg oral finafloxacin for 5 or 10 days vs. oral and IV ciprofloxacin for 10 days in up to 258 patients. The oral formulation of finafloxacin has completed Phase IIa testing to treat urinary tract and Helicobacter pylori infections, while IV finafloxacin completed a Phase I trial last month. A topical formulation of finafloxacin is in Phase III testing to treat acute otitis externa. ...